Review Articles
Surgical Stem Cell Therapy for Advanced Heart Failure Patients
Authors:
Brian A. Bruckner ,
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Brian A.
M.D.
Ali Ghodsizad,
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US; University of Heidelberg, Department of Cardiac Surgery, DE
About Ali
M.D.
Matthias Loebe,
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Matthias
M.D.
Erik Beyer,
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Erik
M.D.
Mahesh Ramchandani,
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Mahesh
M.D.
Arjang Ruhparwar,
University of Heidelberg, Department of Cardiac Surgery, DE
About Arjang
M.D.
Mattias Karck,
University of Heidelberg, Department of Cardiac Surgery, DE
About Mattias
M.D.
Elmar R. Burchardt,
Aastrom Biosciences, Inc., Ann Arbor, Michigan, US; University of Witten-Herdecke, DE
About Elmar R.
M.D., Ph.D.
Amit N. Patel,
University of Utah School of Medicine, US
About Amit N.
M.D.
Michael Reardon
Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Michael
M.D.
Abstract
Despite current treatment, heart failure is a contributing factor in just under 15 million deaths worldwide every year.1 Currently available options for heart failure patients consist of medical management, cardiac transplantation, device therapy, and now stem cell-based therapies. Although cardiac stem cell therapy has been performed in other countries, new surgically based trials with innovative advanced stem cell products are now being initiated in the United States.
How to Cite:
1. Bruckner BA, Ghodsizad A, Loebe M, et al.. Surgical Stem Cell Therapy for Advanced Heart Failure Patients. Methodist DeBakey Cardiovascular Journal. 2009;5(2):13-17. DOI: http://doi.org/10.14797/mdcvj.157
Published on
01 Jan 2009.
Peer Reviewed
Downloads
